Cookie Consent by Free Privacy Policy Generator Update cookies preferences

Session 22

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions


Session 22: Eosinophilic esophagitis – debates & discussions

Thursday, April 25, 4:00 – 5:30 pm
Auditorium Léon Hirsch
Chairs: Emily McGowan (USA) – Bryan Sauer (USA) – Jennifer L. Horsley-Silva (USA) – Neilsen Fernandez-Becker (USA)
  1. Do we know the natural history of EoE? – Adriana Lazarescu (Canada)
  2. What is the best initial therapy for the symptomatic EoE patient?
    I. Proton pump inhibitors  Walter W. Chan (USA) 
    II. Dietary elimination 
    Mark R. Fox (Switzerland) 
    III. Swallowed topical steroids 
    Brent Hiramoto (USA) 
    IV. Dupilumab 
    John O. Clarke (USA) 
  3. Are there any non-invasive means to assess inflammation? – Edoardo V. Savarino (Italy)
  4. Should all EoE providers be performing FLIP for EoE endoscopies? – Abraham Khan (USA)
  5. Does chronic EoE-related esophageal inflammation increase the risk of cancer? David Wang (USA) 
  6. How will we treat EoE in 10 years? – Emily McGowan (USA)